In mice with NASH, translocation of CD36 to the plasma membrane in hepatocytes is associated with lower AMPK (adenosine monophosphate-activated protein kinase) activity and lower FA oxidation (Zhao et al., 2018). Here, CD36 is linked to metabolic dysfunction-associated steatohepatitis.